Gianfranco Pasut

Via Marzolo 5
Padova, 35131, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 75 publications

Conventional and hydrolysable PEGs: comparative evaluation of tissue accumulation, biodistribution and toxicological profile.

Conventional and hydrolysable PEGs: comparative evaluation of tissue accumulation, biodistribution and toxicological profile.

Journal: Biomaterials science

Published: September 07, 2026

Yeast Display Technology Enables Rapid Discovery of Low-Nanomolar Macrocyclic Peptide Inhibitors of Human Angiotensin-Converting Enzyme 2.

Yeast Display Technology Enables Rapid Discovery of Low-Nanomolar Macrocyclic Peptide Inhibitors of Human Angiotensin-Converting Enzyme 2.

Journal: Journal of medicinal chemistry

Published: March 24, 2026

Design, Synthesis, and Pharmacokinetic Profiling of Fluorinated Reversible N-Alkyl Carbamate Derivatives of Psilocin for Sub-Hallucinogenic Brain Exposure.

Design, Synthesis, and Pharmacokinetic Profiling of Fluorinated Reversible N-Alkyl Carbamate Derivatives of Psilocin for Sub-Hallucinogenic Brain Exposure.

Journal: Journal of medicinal chemistry

Published: January 26, 2026

Low, non-psychedelic doses of psilocybin as a novel treatment for MASLD, obesity and type 2 diabetes via 5-HT2B receptor-dependent mechanisms.

Low, non-psychedelic doses of psilocybin as a novel treatment for MASLD, obesity and type 2 diabetes via 5-HT2B receptor-dependent mechanisms.

Journal: Pharmacological research

Published: October 30, 2025

Therapeutic potential of a long-acting form of rhDNase I for the treatment of cystic fibrosis.

Therapeutic potential of a long-acting form of rhDNase I for the treatment of cystic fibrosis.

Journal: International journal of biological macromolecules

Published: October 16, 2025

Therapeutic potential of a long-acting form of rhDNase I for the treatment of cystic fibrosis.

Therapeutic potential of a long-acting form of rhDNase I for the treatment of cystic fibrosis.

Journal: International journal of biological macromolecules

Published: October 16, 2025

High-payload trastuzumab-drug conjugates achieved through hydrophilic Y-shaped pendant PEG linkers for a potent and selective antitumor response.

High-payload trastuzumab-drug conjugates achieved through hydrophilic Y-shaped pendant PEG linkers for a potent and selective antitumor response.

Journal: International journal of biological macromolecules

Published: September 15, 2025

The Role of Structural Dispersity of Polymer Brushes in Determining the Colloidal Stability of Core-Shell Nanoparticles and Their Interaction with Anti-PEG Antibodies.

The Role of Structural Dispersity of Polymer Brushes in Determining the Colloidal Stability of Core-Shell Nanoparticles and Their Interaction with Anti-PEG Antibodies.

Journal: JACS Au

Published: July 09, 2025

PEGylation of Propofol Reduces Its Adsorption to Extracorporeal Membrane Oxygenator (ECMO) Components.

PEGylation of Propofol Reduces Its Adsorption to Extracorporeal Membrane Oxygenator (ECMO) Components.

Journal: Pharmaceutical research

Published: March 24, 2025

Glypican 3 as target therapy to prevent cell migration and proliferation in rhabdomyosarcoma.

Glypican 3 as target therapy to prevent cell migration and proliferation in rhabdomyosarcoma.

Journal: Scientific reports

Published: December 17, 2024

Advances in Nanoparticle Systems for Targeted Therapy against Glioblastoma Multiforme.

Advances in Nanoparticle Systems for Targeted Therapy against Glioblastoma Multiforme.

Journal: International journal of pharmaceutics

Published: October 17, 2024

On the adjuvanticity of hyaluronan: The case of a SARS-CoV-2 vaccine.

On the adjuvanticity of hyaluronan: The case of a SARS-CoV-2 vaccine.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: July 21, 2024

Showing 1-12 of 75

Last Updated: 09/26/2026